APA (7th ed.) Citation

Rodriguez, J., Delgado, M., Viciana, P., Lopez-Ruz, M., Leal, M., Alcacer, F., . . . Moreno, S. (2010). Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study). Journal of the International AIDS Society, 13, P79. https://doi.org/10.1186/1758-2652-13-S4-P79

Chicago Style (17th ed.) Citation

Rodriguez, JM, et al. "Switching to Nevirapine (NVP) Significantly Increases High-density Lipoprotein Cholesterol (HDL-C) in Treatment-experienced Patients (NEVICOR Study)." Journal of the International AIDS Society 13 (2010): P79. https://doi.org/10.1186/1758-2652-13-S4-P79.

MLA (9th ed.) Citation

Rodriguez, JM, et al. "Switching to Nevirapine (NVP) Significantly Increases High-density Lipoprotein Cholesterol (HDL-C) in Treatment-experienced Patients (NEVICOR Study)." Journal of the International AIDS Society, vol. 13, 2010, p. P79, https://doi.org/10.1186/1758-2652-13-S4-P79.